Facebook
Twitter
Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Blog
Jul.03 -- For Pascal Soriot, less is more. He's shed development drugs he sees little chance of becoming viable, relentlessly ...
AstraZeneca CEO Pascal Soriot discusses the drugmaker's business strategy in China, the US “BIOSECURE Act,” and future ...
YouTube
- 6 months ago
Dr. Susan Galbraith, executive vice-president of oncology and R&D at AstraZeneca, discusses the healthcare giant's $2.4bn ...
In July 2021, Alexion was acquired by AstraZeneca, marking the creation of Alexion, AstraZeneca Rare Disease. Alexion and ...
Pascal Soriot, CEO of AstraZeneca, outlines medical development costs and building trust with consumers.
A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never ...
Pascal Soriot, CEO of AstraZeneca, discusses the progress the company is making with cancer drugs.
Some medicines are made in labs by mixing together a number of chemicals. Others, like penicillin, are byproducts of organisms ...
The perfect candidate is someone who aspires to make a difference and is willing to do the right thing, no matter how hard that ...
Our BPD team comes together with a love of science, thriving on collaboration, discussion and making the world a better place ...
Norton safe Web